Antman, an internationally renowned expert in the field of breast cancer, is widely recognized for her development of a standard treatment regimen for sarcoma. Each year through the Special Awards Program, ASCO identifies those individuals whose personal commitment to furthering the progress against cancer has led to tremendous advances in the field. Research scientists and others dedicated to improving the lives of people living with cancer are nominated to receive ASCO’s highest, most prestigious awards.
The collective efforts of this year’s recipients are credited with important strides in bettering the care of children and older adults with cancer in addition to impacting cancer prevention and developing new treatment modalities. “It is our honor to bestow upon Dr. Antman ASCO’s highest award of achievement,” said Gabriel N. Hortobagyi, MD, FACP, ASCO Past President and Chair of the Special Awards Committee.
Antman assumed the positions of Provost of the Medical Campus and Dean of Boston University School of Medicine on May 1, 2005. She came to Boston University from the National Cancer Institute of the National Institutes of Health (NIH) where she served as Deputy Director for Translational and Clinical sciences in 2004 and 2005. Previously, she spent more than 10 years on the faculty of Columbia University College of Physicians and Surgeons.
She has written extensively about impediments to clinical research on cancer, and she has testified before Congress on the need for federal research dollars to support cancer research with articles in the medical literature. She has written more than 300 journal papers and edited five textbooks and monographs, many with multiple editions.
MEDICA.de; Source: Boston University